Investcorp confirms no encumbrance on Nephrocare shares in FY26
Investcorp Private Equity Fund II declared that no encumbrance was created on the shares of Nephrocare Health Services Limited during FY26, other than those previously disclosed. The filing was submitted to BSE and NSE in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
*this image is generated using AI for illustrative purposes only.
Investcorp Private Equity Fund II has confirmed that no encumbrance was created on the shares of nephrocare health services during the financial year ended March 31, 2026. The declaration, submitted to the stock exchanges, assures stakeholders that the shares remain free from new charges or liens, other than those already disclosed. This disclosure provides transparency regarding the financial standing of the promoter's holdings in Nephrocare Health Services Limited.
The confirmation was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Investcorp Private Equity Fund II, being a promoter of the Target Company, along with persons acting in concert, stated that no direct or indirect encumbrance has been created on the shares during the specified period. The filing was addressed to BSE Limited and the National Stock Exchange of India Limited to ensure the information is on public record.
| Entity | Role |
|---|---|
| Investcorp Private Equity Fund II | Promoter |
| Nephrocare Health Services Limited | Target Company |
Copies of the declaration were sent to the Audit Committee and the Company Secretary and Compliance Officer of Nephrocare Health Services Limited for their internal records and necessary action. The company is formerly known as Nephrocare Health Services Private Limited.
Historical Stock Returns for Nephrocare Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.42% | +0.21% | -0.83% | +33.91% | +39.96% | +39.96% |
Does the absence of new encumbrances signal Investcorp's intention to maintain its current holding or prepare for a stake sale?
How might this clean financial position impact Nephrocare's ability to secure future funding or attract strategic partners?
What are the potential growth strategies for Nephrocare Health Services under Investcorp's continued promoter status?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
